| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |